Active Ingredient(s):Levobetaxolol FDA Approved: * February 23, 2000 Pharm Company: *ALCON Category:Vision / Eye Health
Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).
3 Contraindications and side effects
It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular...
* May have multiple approval dates, manufacturers, or labelers.